Financial Ratios Shanghai Sanyou Medical Co., Ltd
Equities
688085
CNE1000040J7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.23 CNY | -0.55% |
|
-2.57% | +3.24% |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | 5.87 | 4.8 | 5.17 | 2.85 | 0.17 | |||
Return on Total Capital | 6.61 | 5.37 | 5.92 | 3.2 | 0.19 | |||
Return On Equity % | 12.02 | 11.93 | 11.16 | 5.75 | 0.59 | |||
Return on Common Equity | 12.02 | 11.57 | 10.82 | 5.09 | 0.6 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | 89.69 | 89.28 | 89 | 77.45 | 67.82 | |||
SG&A Margin | 52.61 | 54.46 | 51.4 | 42.02 | 46.67 | |||
EBITDA Margin % | 29.11 | 25.94 | 28.88 | 27.37 | 8.03 | |||
EBITA Margin % | 26.84 | 24.01 | 27.01 | 22.77 | 3.26 | |||
EBIT Margin % | 26.72 | 23.71 | 26.69 | 22.06 | 1.35 | |||
Income From Continuing Operations Margin % | 30.37 | 32.89 | 31.36 | 24.68 | 2.67 | |||
Net Income Margin % | 30.37 | 31.41 | 29.39 | 20.76 | 2.53 | |||
Net Avail. For Common Margin % | 30.37 | 31.41 | 29.39 | 20.76 | 2.53 | |||
Normalized Net Income Margin | 20.7 | 16.94 | 16.09 | 12.04 | 2.12 | |||
Levered Free Cash Flow Margin | 20.13 | 6.95 | -8.41 | 49.67 | -7.56 | |||
Unlevered Free Cash Flow Margin | 20.13 | 6.97 | -8.39 | 49.7 | -7.4 | |||
Asset Turnover | ||||||||
Asset Turnover | 0.35 | 0.32 | 0.31 | 0.21 | 0.2 | |||
Fixed Assets Turnover | 2.63 | 2.88 | 2.16 | 1.34 | 1.31 | |||
Receivables Turnover (Average Receivables) | 2.13 | 2.64 | 2.45 | 2.71 | 6.71 | |||
Inventory Turnover (Average Inventory) | 0.5 | 0.59 | 0.52 | 0.63 | 0.69 | |||
Short Term Liquidity | ||||||||
Current Ratio | 11.65 | 4.9 | 4.06 | 4.87 | 4.6 | |||
Quick Ratio | 10.86 | 4.32 | 3.31 | 3.79 | 3.4 | |||
Operating Cash Flow to Current Liabilities | 0.63 | 0.62 | 0.64 | 1.38 | 0.05 | |||
Days Sales Outstanding (Average Receivables) | 171.61 | 138.52 | 148.82 | 134.56 | 54.56 | |||
Days Outstanding Inventory (Average Inventory) | 733.42 | 615.94 | 707.04 | 583.23 | 530.1 | |||
Average Days Payable Outstanding | 374.14 | 170.92 | 83.97 | 79.68 | 72.32 | |||
Cash Conversion Cycle (Average Days) | 530.89 | 583.54 | 771.89 | 638.11 | 512.33 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | - | 0.29 | 0.28 | 0.24 | 2.29 | |||
Total Debt / Total Capital | - | 0.29 | 0.28 | 0.24 | 2.24 | |||
LT Debt/Equity | - | 0.14 | 0.12 | 0.04 | 0.8 | |||
Long-Term Debt / Total Capital | - | 0.14 | 0.12 | 0.04 | 0.78 | |||
Total Liabilities / Total Assets | 8.16 | 13.06 | 12.7 | 9.67 | 11.18 | |||
EBIT / Interest Expense | - | 875.37 | 854.25 | 378.9 | 5.23 | |||
EBITDA / Interest Expense | - | 971.75 | 942.31 | 485.69 | 36.66 | |||
(EBITDA - Capex) / Interest Expense | - | 401.51 | 261.02 | 388.94 | 4.78 | |||
Total Debt / EBITDA | - | 0.03 | 0.03 | 0.04 | 1.09 | |||
Net Debt / EBITDA | -10.06 | -4.83 | -2.76 | -5.14 | -14.89 | |||
Total Debt / (EBITDA - Capex) | - | 0.08 | 0.1 | 0.05 | 8.35 | |||
Net Debt / (EBITDA - Capex) | -13.74 | -11.68 | -9.98 | -6.42 | -114.16 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | 10.19 | 51.97 | 9.4 | -29.08 | -1.48 | |||
Gross Profit, 1 Yr. Growth % | 9.82 | 51.29 | 9.06 | -38.28 | -13.72 | |||
EBITDA, 1 Yr. Growth % | 4.12 | 34.56 | 21.83 | -33.21 | -71.42 | |||
EBITA, 1 Yr. Growth % | 1.17 | 35.04 | 23.05 | -40.58 | -86.1 | |||
EBIT, 1 Yr. Growth % | 1.6 | 34.87 | 23.15 | -41.38 | -93.95 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | 20.9 | 64.6 | 4.31 | -44.17 | -89.34 | |||
Net Income, 1 Yr. Growth % | 21.2 | 57.2 | 2.39 | -49.91 | -88 | |||
Normalized Net Income, 1 Yr. Growth % | 23.26 | 24.34 | 3.92 | -46.93 | -82.68 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | -1.57 | 44.43 | 1.21 | -50.65 | -86.83 | |||
Accounts Receivable, 1 Yr. Growth % | 16.75 | 28.26 | 8.89 | -77.66 | 18.88 | |||
Inventory, 1 Yr. Growth % | 36.68 | 30.35 | 27.67 | 13.91 | 39.31 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | 10.84 | 64.41 | 34.77 | -0.38 | 0.72 | |||
Total Assets, 1 Yr. Growth % | 202.95 | 19.54 | 9.72 | 3.2 | 2 | |||
Tangible Book Value, 1 Yr. Growth % | 264.07 | -11.44 | 10.89 | 2.14 | -2.51 | |||
Common Equity, 1 Yr. Growth % | 250.48 | 9.87 | 9.13 | 4.16 | -0.23 | |||
Cash From Operations, 1 Yr. Growth % | 25.6 | 86.94 | 7.63 | 71.46 | -95.9 | |||
Capital Expenditures, 1 Yr. Growth % | -61.79 | 201.01 | 50.77 | -81.23 | 44.33 | |||
Levered Free Cash Flow, 1 Yr. Growth % | -187.23 | -47.54 | -232.47 | -518.64 | -114.99 | |||
Unlevered Free Cash Flow, 1 Yr. Growth % | -187.23 | -47.41 | -231.84 | -519.92 | -114.66 | |||
Dividend Per Share, 1 Yr. Growth % | - | 4.59 | -48.64 | 0.93 | -94.62 | |||
Compound Annual Growth Rate Over Two Years | ||||||||
Total Revenues, 2 Yr. CAGR % | 32.52 | 29.41 | 28.94 | -11.91 | -16.41 | |||
Gross Profit, 2 Yr. CAGR % | 34.34 | 28.89 | 28.45 | -17.96 | -27.03 | |||
EBITDA, 2 Yr. CAGR % | 30.5 | 18.74 | 28.04 | -9.52 | -56.07 | |||
EBITA, 2 Yr. CAGR % | 30.24 | 17.29 | 28.91 | -14.22 | -71.07 | |||
EBIT, 2 Yr. CAGR % | 30.85 | 17.06 | 28.87 | -15.03 | -81.17 | |||
Earnings From Cont. Operations, 2 Yr. CAGR % | 38.32 | 41.07 | 31.03 | -23.69 | -75.61 | |||
Net Income, 2 Yr. CAGR % | 38.13 | 38.03 | 26.87 | -28.39 | -75.48 | |||
Normalized Net Income, 2 Yr. CAGR % | 40.77 | 23.8 | 13.68 | -25.74 | -69.68 | |||
Diluted EPS Before Extra, 2 Yr. CAGR % | 25.5 | 19.24 | 21.11 | -29.03 | -74.51 | |||
Accounts Receivable, 2 Yr. CAGR % | 38.39 | 22.37 | 18.18 | -50.68 | -48.46 | |||
Inventory, 2 Yr. CAGR % | 46.91 | 33.48 | 29 | 20.59 | 25.97 | |||
Net Property, Plant and Equip., 2 Yr. CAGR % | 44.08 | 34.99 | 48.85 | 15.87 | 0.17 | |||
Total Assets, 2 Yr. CAGR % | 107.35 | 90.3 | 14.53 | 6.41 | 2.6 | |||
Tangible Book Value, 2 Yr. CAGR % | 117.9 | 79.56 | -0.9 | 6.43 | -0.21 | |||
Common Equity, 2 Yr. CAGR % | 112.3 | 96.23 | 9.5 | 6.61 | 1.94 | |||
Cash From Operations, 2 Yr. CAGR % | 97.93 | 53.23 | 41.85 | 35.84 | -73.49 | |||
Capital Expenditures, 2 Yr. CAGR % | -29.09 | 7.25 | 113.03 | -46.8 | -47.95 | |||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.89 | -32.35 | -16.64 | 135.49 | -20.77 | |||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.89 | -32.27 | -16.73 | 135.29 | -21.54 | |||
Dividend Per Share, 2 Yr. CAGR % | - | - | -26.68 | -28 | -76.69 | |||
Compound Annual Growth Rate Over Three Years | ||||||||
Total Revenues, 3 Yr. CAGR % | 40.77 | 38.71 | 22.36 | 5.65 | -8.56 | |||
Gross Profit, 3 Yr. CAGR % | 49.09 | 39.77 | 21.91 | 0.61 | -16.57 | |||
EBITDA, 3 Yr. CAGR % | 125 | 32.12 | 19.76 | 3.28 | -38.15 | |||
EBITA, 3 Yr. CAGR % | 168.32 | 32.12 | 19.18 | -0.21 | -53.02 | |||
EBIT, 3 Yr. CAGR % | 178.18 | 32.17 | 19.05 | -0.89 | -64.79 | |||
Earnings From Cont. Operations, 3 Yr. CAGR % | 193.51 | 46.58 | 27.56 | -1.4 | -60.41 | |||
Net Income, 3 Yr. CAGR % | 183.52 | 44.21 | 24.95 | -6.93 | -60.52 | |||
Normalized Net Income, 3 Yr. CAGR % | 152.54 | 35.06 | 16.78 | -11.82 | -54.28 | |||
Diluted EPS Before Extra, 3 Yr. CAGR % | 150.81 | 31.52 | 13.02 | -9.96 | -59.52 | |||
Accounts Receivable, 3 Yr. CAGR % | 60.61 | 34.92 | 17.7 | -32.17 | -33.87 | |||
Inventory, 3 Yr. CAGR % | 27.53 | 41.17 | 31.51 | 23.76 | 26.54 | |||
Net Property, Plant and Equip., 3 Yr. CAGR % | 71.93 | 50.56 | 34.92 | 30.2 | 10.58 | |||
Total Assets, 3 Yr. CAGR % | 70.71 | 72.57 | 58.39 | 10.62 | 4.92 | |||
Tangible Book Value, 3 Yr. CAGR % | 78.42 | 61.41 | 52.91 | 0.1 | 3.36 | |||
Common Equity, 3 Yr. CAGR % | 74.44 | 70.45 | 61.37 | 7.69 | 4.28 | |||
Cash From Operations, 3 Yr. CAGR % | 53.25 | 94.2 | 36.21 | 51.1 | -57.71 | |||
Capital Expenditures, 3 Yr. CAGR % | -5.96 | 14.82 | 20.14 | -5.21 | -25.81 | |||
Levered Free Cash Flow, 3 Yr. CAGR % | - | -15.16 | -15.37 | 42.76 | -5.97 | |||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | -15.09 | -15.43 | 42.79 | -6.72 | |||
Dividend Per Share, 3 Yr. CAGR % | 35.46 | - | - | -18.44 | -69.67 | |||
Compound Annual Growth Rate Over Five Years | ||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 35.91 | 15.67 | 5.06 | |||
Gross Profit, 5 Yr. CAGR % | - | - | 40.46 | 12.94 | -0.71 | |||
EBITDA, 5 Yr. CAGR % | - | - | 79.8 | 13.55 | -19.71 | |||
EBITA, 5 Yr. CAGR % | - | - | 100.4 | 11.16 | -32.26 | |||
EBIT, 5 Yr. CAGR % | - | - | 104.49 | 10.76 | -43.07 | |||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 112.58 | 12.89 | -34.18 | |||
Net Income, 5 Yr. CAGR % | - | - | 105.54 | 8.99 | -34.86 | |||
Normalized Net Income, 5 Yr. CAGR % | - | - | 83.51 | 6.33 | -31.9 | |||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | 87.45 | 2.83 | -37.6 | |||
Accounts Receivable, 5 Yr. CAGR % | - | - | 42.06 | -9.78 | -15.41 | |||
Inventory, 5 Yr. CAGR % | - | - | 28.11 | 32.55 | 29.27 | |||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 62.3 | 35.58 | 19.77 | |||
Total Assets, 5 Yr. CAGR % | - | - | 45.52 | 42.23 | 33.13 | |||
Tangible Book Value, 5 Yr. CAGR % | - | - | 41.02 | 36.64 | 28.91 | |||
Common Equity, 5 Yr. CAGR % | - | - | 44.79 | 41.28 | 34.29 | |||
Cash From Operations, 5 Yr. CAGR % | - | - | 48.58 | 68.33 | -29.22 | |||
Capital Expenditures, 5 Yr. CAGR % | - | - | 30.42 | -15.6 | -14.02 | |||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 27.63 | -17.57 | |||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 27.65 | -17.93 | |||
Dividend Per Share, 5 Yr. CAGR % | - | - | 5.97 | - | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















